The elevated serum kallistatin level and its positive correlation with HbA1c in our T2D patient group corroborates the results of previous studies and confirms the key role of persistent hyperglycemia in the upregulation of kallistatin production [5,6]. The gene discussed is SERPINA4; the disease is Hyperglycemia.